Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
Internal e-mail exhorts university staff to lobby Congress for increased funds to increase number of children declared mentally ill.
The Senate Finance committee is cracking down on drug industry "educational grants" to physicians, medical associations and "patient advocacy" groups.
Authors of the American College of Neuropsychopharmacology Task Force on SSRIs and Suicidal Behavior in Youth: their known ties to the pharmaceutical industry
”SO WHY,” he asks, “DID American doctors prescribe $7 billion worth of Vioxx after Merck and the Food and Drug Administration knew all this?”
"With conflicts of interest increasingly casting doubt on the credibility of medical research, a leading surgery journal is cracking down on authors who fail to disclose links to industry, threatening to temporarily blacklist them."
" A causal role for antidepressants in inducing suicidality has been established in pediatric patients."
A front page report in The Wall Street Journal underscores the inherent flaw in the "peer review" vetting system used by science journals.
The year 2005 will surely be the year in which the pharmaceutical industry’s
dirty tricks and underhanded tactics were revealed for what they are–a
menace to society.
Responding to the AHRP Infomail–Medical Journal Editor Finds Truth Hard to
Track Down (December 27) Eddie Vos,* expert nutrition specialist offers
comments about the13-year ‘"investigation" of alleged research misconduct by
an Indian physician, as reported in the Wall Street Journal (December 27).
The National Institutes of Health's reinstatement of Dr. Jonathan Fishbein settles a two-year battle that prompted both congressional and federal investigations.
On Tuesday evening, 38 U.S. Senators with about $13.4 million in pharmaceuticaql stock holdings approved a sweetheart deal absolving the drug / vaccine industry from liability .
